armetheon.com
Home - ArmetheonArmetheon, Inc., is a privately held, San Francisco Bay area-based clinical stage biopharmaceutical company focused on the development of novel drug...
http://www.armetheon.com/
Armetheon, Inc., is a privately held, San Francisco Bay area-based clinical stage biopharmaceutical company focused on the development of novel drug...
http://www.armetheon.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
16x16
32x32
64x64
128x128
PERFECT PRIVACY, LLC
12808 Gr●●●●●●●●kwy West
Jack●●●●ille , FL, 32258
US
View this contact
PERFECT PRIVACY, LLC
12808 Gr●●●●●●●●kwy West
Jack●●●●ille , FL, 32258
US
View this contact
PERFECT PRIVACY, LLC
12808 Gr●●●●●●●●kwy West
Jack●●●●ille , FL, 32258
US
View this contact
BUY YOUR DOMAIN
12
YEARS
9
MONTHS
22
DAYS
REGISTER.COM, INC.
WHOIS : whois.register.com
REFERRED : http://www.register.com
PAGES IN
THIS WEBSITE
15
SSL
EXTERNAL LINKS
9
SITE IP
216.21.224.199
LOAD TIME
0 sec
SCORE
6.2
Home - Armetheon | armetheon.com Reviews
https://armetheon.com
Armetheon, Inc., is a privately held, San Francisco Bay area-based clinical stage biopharmaceutical company focused on the development of novel drug...
armetheon.com
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development - Armetheon
http://armetheon.com/andrew-lam-vice-president-product-development
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development. Menlo Park, CA, May 8, 2015. A specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced the appointment of Andrew C. Lam. Co-founder and President of Armetheon. Which has achieved total sales in excess of $1.5 billion annually since its release in 2002. In 2002, Mr. Lam was the recipient of the Johnson Medal for Research and Development, t...Armetheon...
Investors - Armetheon
http://armetheon.com/investors
Armetheon, Inc. is a privately held biopharmaceutical company developing and commercializing innovative medicines addressing major unmet needs in cardiovascular disease, initially in thrombosis and cardiac arrhythmias. Armetheon focuses on improved therapies with the goal of increased efficacy, safety, and utility, targeting specialty markets with clearly defined regulatory pathways. Armetheon’s two late-stage small molecule drug candidates are being investigated for use in the areas of oral anticoagulat...
Physicians - Armetheon
http://armetheon.com/physicians
Armetheon is partnering with healthcare providers, physicians, and administrators to deliver superior alternatives for patients with cardiovascular disease. Our researchers have vast experience in cardiovascular disease, treatments and pharmacology. We work with physicians to identify areas of unmet need and explore the potential for treatment. Our current projects and programs include:. Alternatives to warfarin and non-monitored therapy (NMT). Anti-coagulation in patients with kidney problems.
Patients - Armetheon
http://armetheon.com/patients
Armetheon is committed to improving the lives of patients with cardiovascular disease by developing potential drug therapies that fulfill unmet needs. We are working to advance alternative treatments that can deliver superior effectiveness to existing medical therapies or offer new therapies for patients who do not have clinically efficacious options. Through innovation and research, we’re developing potential drugs that could assist patients with a variety of conditions, including:.
Newsroom - Armetheon
http://armetheon.com/newsroom
Armetheon Completes Acquisition of Budiodarone and Plans Development for the Treatment of Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators. May 26, 2016. Milpitas, CA, May 26, 2016 Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced … Read More. Armetheon to Present at the 14th Annual BIO Investor Forum. October 14, 2015. October 8, 2015. September 22, 2015. September 8, 2015. Armetheon Expa...
TOTAL PAGES IN THIS WEBSITE
15
Atheneos Capital - PORTFOLIO
http://www.atheneoscapital.com/PORTFOLIO.html
The person who says something is impossible. Should not interrupt the person who is doing it. Athenagen (later renamed CoMentis)* is dedicated to the discovery and development of small-molecule drugs to treat Alzheimer’s disease. April, 2005 (renamed CoMentis following merger with Zapaq, Inc. in 2007) (South San Francisco, CA). Total funds raised;. Sanderling Ventures, Clarus Ventures, Index ventures, Charter Life Sciences, Astellas Pharma, Inc. and. Astellas Venture Capital LLC. Total funds raised;.
Healthcare Clients - Burns McClellan
http://burnsmcclellan.com/clients
Investor and Public Relations for Life Sciences Organizations. 257 Park Avenue South, 15th Flr., New York, NY. 212) 213.0006 info@burnsmc.com. Our Partners in Europe. 1 Fetter Ln, London EC4A 1BR, United Kingdom. Weill Cornell Medical College. Foundation for Prader Willi Research. Web Design by Second Language.
Atheneos Capital - WEB LINKS
http://www.atheneoscapital.com/WEB-LINKS.html
The person who says something is impossible. Should not interrupt the person who is doing it. 5 April 2012: “ Freakonomics of factors that determine failure of a biotech company. A lecture given at QB3: UCSF By Dr M.(Ken) Kengatharan, Founder and General Partner, Atheneos Capital. Ldquo;We would accomplish many more things if we did not think of them as impossible.” - Vince Lombardi.
Investments | AshHill
http://www.ashhill.net/investments
SinuSys developed and is marketing a maxillary sinus dilator for the treatment of chronic sinusitis, a condition that affects more than 37 million Americans. The standard course of treatment is currently antibiotics for sinus infections, a balloon dilation system or surgery. The Vent-OS Sinus Dilation system offers a less invasive alternative to surgery. It was U.S. FDA cleared for diagnostic and therapeutic procedures in January 2014 and is on the market. Created by The Deciding Factor Inc.
Armetheon closes $24 million Series B financing | AshHill
http://www.ashhill.net/armetheon-closes-24-million-series-b-financing
Armetheon closes $24 million Series B financing. Menlo Park, CA. February 5, 2015 Armetheon, Inc. A cardiovascular disease-focused, clinical stage, specialty biopharmaceutical company, today announced the successful closing of $24.3 million in Series B financing. The financing was co-led by Hercules Bioventure Partners and Capital TEN II, with participation from new and existing investors. The funds will mainly be used to advance Armetheon’s lead clinical candidate, tecarfarin. George Lee, Ph.D.,...Heath...
Armetheon Completes $7.0 Million Series A Financing | AshHill
http://www.ashhill.net/armetheon-completes-7-0-million-series-a-financing
Armetheon Completes $7.0 Million Series A Financing. Menlo Park, CA August 28, 2014. The quality of our science and the team is reflected by the stellar syndicate of both institutional and angel investors in this over-subscribed Series A round, said M. (Ken) Kengatharan, PhD, Co-Founder, President and COO. And Atheneos Capital ( http:/ www.atheneoscapital.com/. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anticoagulation and atrial fibrillation. Locust Wa...
TOTAL LINKS TO THIS WEBSITE
9
Arkansas Electric Meter School | Confernce Hub | Walton College | University of Arkansas
Welcome to the 66. Annual Electric Meter School October 1 - 4, 2018. The University of Arkansas Electric Meter School will be held at:. The Hilton Garden Inn. 1325 N. Palak Drive. Show in Google Maps. Registration is only $150 per person, including students, vendors, instructors, and planning committee members. Student fees include tuition, materials, refreshment breaks, and two hosted lunches. No refunds will be given; however, substitutions are welcomed at any time. Participants can earn up to 2.0 ...
armetfrancis.com
Accueil, entreprise de gardiennage- Paris 7ème | Armet Gardiennage
01 39 65 79 51. Rappel immédiat et gratuit. Nous contacter : agsp@sfr.fr. 10 Rue Croix De L'Épine. Tél. :. 01 39 65 79 51. 01 39 65 93 08. 06 86 73 81 97. Rappel immédiat et gratuit. Vous offre toute une gamme de services liés à la sécurité, au gardiennage et à la surveillance. Créée en avril 2008, notre entreprise vous propose diverses prestations qui intéressent aussi bien les professionnels que les particuliers. Nous pouvons assurer la sécurité d’une zone d’accueil. Création site web.
Armet Group - Armet Group
Knowledge is power - and knowing who does and doesn't belong is more critical than ever before. You can trust ARMET Group to guide you through the latest in identification management solutions for business, education, healthcare and government. Our goal: giving you the power to protect your people, places and things through secure identification management and access control. Secure ID - the power to safeguard your human, structural and knowledge-based assets. 8203;Visit Solutions Now. ARMET Group promo...
Home - Armetheon
Cardiovascular Diseases are the. Leading Cause of Death and Disability. An Emerging Pharmaceutical Company. Needs in Cardiovascular Disease. Through Innovative Research for. The Benefit of Patients and Physicians. Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development. May 8, 2015. Menlo Park, CA, May 8, 2015 Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular … Read More. March 9, 2015. This mid-clinical tr...
armethod.com - Registered at Namecheap.com
This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! The Sponsored Listings displayed above are served automatically by a third party. Neither Parkingcrew nor the domain owner maintain any relationship with the advertisers.
armethos (Jake Ziegler) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 12 Years. This deviant's full pageview. Last Visit: 409 weeks ago. This is the place where you can personalize your profile! Santa ...
Armethyle (Xavia) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Digital Art / Hobbyist. Deviant for 1 Year. 1 Month Core Membership. Daily Pageviews ». Last Visit: 46 minutes ago. Why," you ask? 170 / 1,000.
Armeti Kft. - Főoldal
Vás és fiz. feltételek. Cégünk nagykereskedelemmel foglalkozik,. Amennyiben magánemberként szeretne vásárolni, szívesen adunk tájékoztatást Partnereink elérhetőségéről. A webáruházban figyelemmel kísérheti rendelésének alakulását. Armeti pamut köntös M 10 forintért-részletek a leírásban! Armeti pamut köntös S 10 forintért-részletek a leírásban! ARCHER lánc 3/8x1,6mm 25FT (75LP). ARCHER lánc 3/8x1,6mm 100FT (75LP). Armeti állvány 10 forintért-részletek a leírásban! Fátyolfólia 17 gr fehér 1,1m x 5 fm (K80).
SOCIAL ENGAGEMENT